EDVANCI
Actelion Pharmaceuticals Ltd
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87344068 |
| Registration Number | 5472764 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Cheryl Foytlin |
| Attorney Name | Cheryl Foytlin |
| Attorney Docket Number | T41808US1 |
| Law Office Assigned | L50 |
| Employee Name | O'BRIEN, ELIZABETH A |
Timeline
| 2017-02-21 | Application Filed |
| 2018-03-06 | Published for Opposition |
| 2018-05-22 | Location: PUBLICATION AND ISSUE SECTION |
| 2018-05-22 | Status: Live/Registered |
| 2018-05-22 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Actelion Pharmaceuticals Ltd |
| Entity Statement | société anonyme (sa) |
| Address | Gewerbestrasse 16 Allschwil CH |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical anti-allergic preparations and substances; vaccines |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-02-24 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-02-28 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-05-08 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2017-05-09 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-05-09 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-05-09 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-09-26 | 7 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2017-10-04 | 8 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-10-12 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-10-12 | 10 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2017-11-06 | 11 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-11-06 | 12 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-11-06 | 13 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-01-03 | 14 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-01-05 | 15 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-01-05 | 16 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-01-29 | 17 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-02-14 | 18 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-03-06 | 19 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-03-06 | 20 NPUB E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-03-06 | 21 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-03-06 | 22 ARAA I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2018-05-22 | 23 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2023-05-22 | 24 REM1 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 EDVANCI 98560473 not registered Live/Pending |
Actelion Pharmaceuticals Ltd 2024-05-21 |
 EDVANCI 87344068 5472764 Live/Registered |
Actelion Pharmaceuticals Ltd 2017-02-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 